A detailed history of Tema Etfs LLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Tema Etfs LLC holds 31,795 shares of ARWR stock, worth $1.31 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
31,795
Previous 35,359 10.08%
Holding current value
$1.31 Million
Previous $559 Million 96.29%
% of portfolio
0.09%
Previous 0.15%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 24, 2025

SELL
$14.71 - $34.49 $52,426 - $122,922
-3,564 Reduced 10.08%
31,795 $1.1 Billion
Q2 2025

Aug 13, 2025

BUY
$9.99 - $16.97 $54,605 - $92,758
5,466 Added 18.29%
35,359 $559 Million
Q1 2025

May 14, 2025

SELL
$12.74 - $21.53 $402,711 - $680,563
-31,610 Reduced 51.4%
29,893 $381 Million
Q4 2024

Feb 14, 2025

BUY
$17.7 - $26.34 $1.09 Million - $1.62 Million
61,503 New
61,503 $1.16 Billion

Others Institutions Holding ARWR

About ARROWHEAD PHARMACEUTICALS, INC.


  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $4.37B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track Tema Etfs LLC Portfolio

Follow Tema Etfs LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tema Etfs LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tema Etfs LLC with notifications on news.